Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 16-30 of 101
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiersStudying Cortical Lesions in MS: Future Research Directions
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiersmIDH Gliomas Explained: Characteristics and Management Strategies
Climate Change in the Clinic: Examining Neurological Impacts
NeuroFrontiersClimate Change in the Clinic: Examining Neurological Impacts
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiersVorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Optimizing TK2d Care Through a Multidisciplinary Approach
NeuroFrontiersOptimizing TK2d Care Through a Multidisciplinary Approach
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
On the Frontlines of CIDPDecoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
On the Frontlines of CIDPEvolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Understanding CIDP: A Roadmap to Diagnosis
On the Frontlines of CIDPUnderstanding CIDP: A Roadmap to Diagnosis
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiersInvestigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiersNext Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
Monitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
NeuroFrontiersMonitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiersDuchenne Muscular Dystrophy Management: Analyzing Current Approaches
Advances in MS Management: Current and Future Directions
NeuroFrontiersAdvances in MS Management: Current and Future Directions
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiersDiagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiersFrom Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
